《慢性阻塞性肺疾病全球创议(2024版)》解读:吸入治疗管理

Interpretation of the Global Initiative for Chronic Obstructive Lung Disease(2024 report):inhalation therapy management

慢性阻塞性肺疾病是一种慢性气道疾病, 吸入制剂是其治疗的基石。正确选择和使用吸入装置对于提高吸入治疗的获益-风险比至关重要。《慢性阻塞性肺疾病全球创议(2024版)》在"吸入治疗管理"章节整合了吸入装置分类及特性、药物气溶胶颗粒的空气动力学特性、正确使用药物递送系统的能力、吸入装置的选择和吸入技术教育等内容。本文对该章节进行更为详细的解读, 旨在指导临床医生更好地对慢性阻塞性肺疾病吸入治疗进行管理。

Chronic obstructive pulmonary disease(COPD)is a chronic airway condition where inhalation medications are a cornerstone of treatment.The proper use of inhalation devices is crucial for enhancing the benefit-risk ratio of inhalation therapy.The 2024 GOLD report integrates in the chapter of inhalation therapy management sections on Classification and Characteristics of Inhalation Devices,Aerodynamic Characteristics of Medicinal Aerosol Particles,Capability for Correct Use of Drug Delivery Systems,Selection of Inhalation Devices,and Inhalation Technique Education.This article offers a detailed interpretation of this chapter,aiming to guide the clinicians to better manage inhalation treatment for COPD.